Bibliography
- Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority — A WHO resolution. N Engl J Med. 2017;377(5):414–417.
- Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272.
- Fraimow H, Nahra R. Resistant gram-negative infections. Crit Care Clin. 2013;29(4):895–921.
- Singer M, Deutschman CS, Seymour C, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
- Giamarellos-Bourboulis EJ, Plachouras D, Tzivra A, et al. Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study. Clin Exp Immunol. 2004;135(2):240–246.
- Pantelidou I-M, Galani I, Georgitsi M, et al. Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype. Antimicrob Agents Chemother. 2015;59(11):7036–7043.
- Hellenic Sepsis Study Group. [accessed 3 December 2019]. Available from: http://hssg.sepsis.gr
- Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–1256.
- Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
- Van Der Poll T, Van De Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407–420.
- Giamarellosbourboulis E, Koussoulas V, Panagou C, et al. Experimental sepsis using Pseudomonas aeruginosa: the significance of multi-drug resistance. Int J Antimicrob Agents. 2004;24(4):357–361.
- Zhou Z, Ren J, Liu H, et al. Pandrug-resistant isolate of Klebsiella pneumoniae causes less damage than drug-susceptible isolates in a rabbit model. Clin Invest Med. 2011;34(1):38–44. http://www.ncbi.nlm.nih.gov/pubmed/21291634. Accessed March 19, 2018.
- Wu HP, Chen CK, Chung K, et al. Serial cytokine levels in patients with severe sepsis. Inflamm Res. 2009;58(7):385–393.
- Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11(2):R49.
- Oberholzer A, Souza SM, Tschoeke SK, et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock. 2005;23(6):488–493. http://www.ncbi.nlm.nih.gov/pubmed/15897799. Accessed December 18, 2019.
- Lymperopoulou K, Velissaris D, Kotsaki A, et al. Angiopoietin-2 associations with the underlying infection and sepsis severity. Cytokine. 2015;73(1):163–168.
- Blot S, Vandewoude K, De Bacquer D, et al. Nosocomial bacteremia caused by antibiotic‐resistant gram‐negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002;34(12):1600–1606.
- Parker CM, Kutsogiannis J, Muscedere J, et al. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care. 2008;23(1):18–26.
- Mouloudi E, Protonotariou E, Zagorianou A, et al. Bloodstream infections caused by metallo- β -lactamase/Klebsiella pneumoniae carbapenemase–producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol. 2010;31(12):1250–1256.
- Papadimitriou-Olivgeris M, Marangos M, Christofidou M, et al. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis. 2014;46(9):642–648.
- Zilberberg MD, Shorr AF, Micek ST, et al. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596.
- Fisher J, Douglas JJ, Linder A, et al. Elevated plasma angiopoietin-2 levels are associated with fluid overload, organ dysfunction, and mortality in human septic shock. Crit Care Med. 2016;44(11):2018–2027.
- Siner JM, Bhandari V, Engle KM, et al. Elevated serum Angiopoietin 2 levels are associated with increased mortality in sepsis. Shock. 2009;31(4):348–353.